Articles Referencing XBI

Biotechnology ETF Investing 101 - ETF News And Commentary
5/20/2013, 11:03 am from Zacks.com in Investing, ETFs
With ever-increasing health care spending and insatiable demand
for new drugs, the biotechnology sector looks poised for good
growth going forward. Furthermore, the U.S. biotech... Read >>

Acorda Therapeutics, Inc. (ACOR): Today's Most Compelling Stock Buy
5/13/2013, 12:15 pm from David Moenning in Investing, Investing Ideas, Stocks, US Markets
SoTM Bull's Eye Report - Today's Most Compelling Buy Monday, May 13, 2013 At StateoftheMarkets.com , we strive to "own the best and ignore the... Read >>

S&P Highlights Biotech ETFs
5/10/2013, 7:39 am from Benzinga in Investing, ETFs, Investing Ideas
Bolstered by an accommodating Food & Drug Administration and
promising recent clinical results for drugs aimed at treating
conditions such as hepatitis C and multiple... Read >>

Pharmacyclics Inc. (PCYC): Today's Most Compelling Stock Buy
5/7/2013, 1:53 pm from David Moenning in Investing, Investing Ideas, Stocks, US Markets
SoTM Bull's Eye Report - Today's Most Compelling Buy Tuesday, May 7, 2013 At StateoftheMarkets.com , we strive to "own the best and ignore the... Read >>

Polycyclics Inc. (PCYC): Today's Most Compelling Stock Pick
4/26/2013, 3:20 pm from David Moenning in Investing, Investing Ideas, Stocks, US Markets
SoTM Bull's Eye Report - Today's Most Compelling Buy Friday, April 26, 2013 At StateoftheMarkets.com , we strive to "own the best and ignore the... Read >>

United Therapeutics Corp. (UTHR): Today's Most Compelling Stock Buy
4/22/2013, 2:31 pm from David Moenning in Investing, Investing Ideas, Stocks, Technology
SoTM Bull's Eye Report - Today's Most Compelling Buy Monday, April 22, 2013 At StateoftheMarkets.com , we strive to "own the best and ignore the... Read >>

Biotech Mutual Funds Show ETFs Are The Place to Be
4/22/2013, 12:41 pm from Benzinga in Investing, ETFs, Investing Ideas
In March, we compared a a popular energy sector ETF and a comparable mutual
fund with the idea being to figure out when relevant factors
are considered, which vehicle is best for investors. ... Read >>

Vertex News Lifts Biotech ETFs
4/19/2013, 10:52 am from Benzinga in Investing, ETFs, Investing Ideas
Shares of biotechnology firm Vertex Pharmaceuticals (NASDAQ: VRTX ) are soaring by
more than 55 percent early Friday and have touched a new all-time
high after the company announced late... Read >>

3 Sector ETFs Surviving This Slump - ETF News And Commentary
4/18/2013, 3:16 pm from Zacks.com in Investing, ETFs
It has definitely been a rough couple of days in the stock
market. The S&P 500, as represented by SPY , has lost about 2.3% in the past five days,
a shift in the trends that investors... Read >>

Under The Hood: An Unheralded Biotech ETF
4/11/2013, 1:53 pm from Benzinga in Investing, ETFs, Investing Ideas
Another day, another set of fresh all-time highs for the major
biotechnology ETFs . Biotech
investors were treated to the same feat in late March , but as health care
has continued to be a... Read >>

Biotech Breakout Boosting ETFs
3/28/2013, 3:21 pm from Benzinga in Investing, ETFs, Investing Ideas
The four horsemen of the biotechnology - Amgen (NASDAQ: AMGN ), Biogen Idec
(NASDAQ: BIIB ),
Celgene (NASDAQ: CELG ) and Gilead
Sciences (NASDAQ: GILD ) - all hit new
52-week highs... Read >>

Exploring No Man's Land ETFs
3/15/2013, 2:23 pm from Benzinga in Investing, ETFs, Investing Ideas
First, the phrase "no man's land ETFs " needs to be
defined and explained. To be sure, it is not as negative as some
might be thinking. Actually, it is not negative at all.... Read >>

Regeneron Pharmaceuticals Inc (REGN): Today's Most Compelling Buy
3/14/2013, 12:52 pm from David Moenning in News Headlines, US Markets, Investing Ideas, Taxes
SoTM Bull's Eye Report - Today's Most Compelling Buy Thursday, March 14, 2013 At StateoftheMarkets.com , we strive to "own the best and ignore the... Read >>

If Stocks Keep Soaring, Get to Know These Leveraged ETFs
3/8/2013, 2:16 pm from Benzinga in Investing, ETFs, International, Investing Ideas
Another day, another intrday record for the Dow Jones Industrial
Average. Buoyed by a stronger-than-expected February jobs report,
U.S. stocks continue to grind higher. Friday's action is of... Read >>

Spectrum Pharmaceuticals, Inc. (SPPI) Ex-Dividend Date Scheduled for December 18, 2012
12/14/2012, 9:00 am from NASDAQ.com News in News Headlines, Stocks
Spectrum Pharmaceuticals, Inc. ( SPPI ) has announced
an ex-dividend date of December 18, 2012 and a cash dividend
payment of $0.15 per share scheduled for December 28, 2012.
Shareholders who... Read >>